View the blend Research Peptides Australia
What is FIRDAPSE
14 When selecting a starting dose for a new route of administration for a patient who desires to switch therapies but was already within an acceptable range per testosterone levels and symptomatic control, we can use bioavailability estimates as a starting point for selecting a dose
Weeks 1-4: 0.25 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 5-8: 0.5 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 9-12: 1.0 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 13-16: 1.7 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Week 17 and beyond: 2.4 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Some providers modify this schedule based on individual tolerance
If your body doesnt have normal B12 levels, you might have a deficiency and should contact your healthcare team
As absolute abstinence is difficult to achieve, applying hepatoprotective agents is necessary
